Hussain Alamdar, Faryal Rani, Nore Beston F, Mohamed Abdalla J, Smith C I Edvard
Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Clinical Research Center, SE-141 86 Huddinge, Sweden.
Biochem Biophys Res Commun. 2009 Dec 18;390(3):892-6. doi: 10.1016/j.bbrc.2009.10.070. Epub 2009 Oct 20.
Recurrent chromosomal translocations have long been implicated in various types of lymphomas and other malignancies. Novel recurrent t(5;9)(q33;q22) has been recently discovered in un-specified peripheral T-cell lymphoma. To elucidate the role of this translocation, the corresponding fusion construct encoding the N-terminal portion of the ITK kinase and the C-terminal catalytic region of the SYK kinase was generated. We herein show that the ITK-SYK fusion-protein is constitutively active. Moreover, we demonstrate that ITK-SYK is phosphorylated on key tyrosine residues and is capable of potently phosphorylating the related adapter proteins BLNK and SLP-76. In transiently transfected cells, SYK was phosphorylated at Y352 but not detectably at the activation-loop tyrosines Y525/Y526. In contrast, ITK-SYK was phosphorylated both at Y212 and the activation-loop tyrosines Y385/Y386, corresponding to Y352 and Y525/Y526 in SYK, respectively. In resting primary lymphocytes, ITK-SYK predominantly localizes to the cell surface. In addition, we demonstrate that following stimulation, the ITK-SYK fusion-protein in cell lines translocates to the cell membrane and, moreover, that this phenomenon as well as SLP-76 phosphorylation are blocked upon phosphatidylinositol-3-kinase (PI3-kinase) inhibition.
长期以来,反复出现的染色体易位一直与各种类型的淋巴瘤及其他恶性肿瘤有关。最近在未明确的外周T细胞淋巴瘤中发现了新的反复出现的t(5;9)(q33;q22)。为了阐明这种易位的作用,构建了编码ITK激酶N端部分和SYK激酶C端催化区域的相应融合构建体。我们在此表明,ITK-SYK融合蛋白具有组成性活性。此外,我们证明ITK-SYK在关键酪氨酸残基上被磷酸化,并且能够有效地磷酸化相关衔接蛋白BLNK和SLP-76。在瞬时转染的细胞中,SYK在Y352处被磷酸化,但在激活环酪氨酸Y525/Y526处未检测到磷酸化。相比之下,ITK-SYK在Y212以及激活环酪氨酸Y385/Y386处被磷酸化,分别对应于SYK中的Y352和Y525/Y526。在静息原代淋巴细胞中,ITK-SYK主要定位于细胞表面。此外,我们证明在刺激后,细胞系中的ITK-SYK融合蛋白转位至细胞膜,而且这种现象以及SLP-76磷酸化在磷脂酰肌醇-3激酶(PI3激酶)抑制后被阻断。